Revance Therapeutics shares owned by Glazer Capital
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Glazer Capital
from 13F filings
Historical chart of Glazer Capital investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Glazer Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Glazer Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $249k | 3.2k | 77.57 |